ArticleInternational journal of clinical and experimental pathology2015

Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma.

Ji An Hwang et al.PubMed ↗Full text ↗

No numbers read from the abstract.